Results of the study of efficacy and tolerance of Tivor-L® in combination treatment of patients with non-ST elevation acute coronary syndrome and unstable angina

Cardiologist, General practitioner

Ivano-Frankivsk National Medical University, Ukraine Department of Internal Medicine No. 2 and Nursing

Abstract. The article presents the study of comparative evaluation of the efficacy and tolerability – Tivor-L, solution for infusion, in patients with non-STEMI acute coronary syndrome and unstable angina.

Кey words: Acute coronary syndrome, myocardial infraction, Тivor-L, arginine, carnitine.

29 November, 2016

Authors:

I.P. Vakalyuk

Products:

Tivor-L®

Learn more

Cardiologist

Endothelitis in the pathogenesis of chronic CHD: clinical manifestations and treatment approaches

Cardiologist

Cardioprotector effect of nitrogen oxide donor in patients with hypertension

Cardiologist

Endothellitis as an important factor of Long Covid and ways of medical correction

General practitioner

Possibilities of using a fixed combination of levocarnitine and L-arginine in chronic ischemic heart disease

Cardiologist

New opportunities of using an ischemic cascade blocker in the therapy of acute myocardial infarction

The anesthesiologist and specialist on medical emergency conditions

Factors related to the improvement of the right ventricular function in patients with pulmonary embolism at short-term follow-up